Results 221 to 230 of about 365,394 (311)
Intracranial venous thrombosis imaging by anatomical location: an educational review with mimics and diagnostic pitfalls. [PDF]
Delgado AF +5 more
europepmc +1 more source
Whole‐blood biomimetic engineering transforms liquid metal nanoparticles into a tripartite immunotherapeutic platform that orchestrates regulatory T‐cell depletion, photothermal‐induced immunogenic cell death, and activation of the stimulator of interferon genes pathway.
Nina Sang, Eijiro Miyako
wiley +1 more source
Early endovenous laser ablation with 1940-nm wavelength for symptomatic marginal veins in pediatric Klippel-Trenaunay syndrome: A 4-year retrospective cohort study on safety, limb hypertrophy, and quality of life. [PDF]
Mahmoud AA, Basta MGZ, Hagag MA.
europepmc +1 more source
Under normal conditions, MACF1 interacts with Rab14 and facilitates KIF16B‐mediated FGFR vesicle trafficking along microtubules to the plasma membrane, thereby supporting BMSC differentiation. In contrast, chronic GC exposure suppresses MACF1 expression, disrupting this transport and causing intracellular FGFR retention, which blunts osteogenic ...
Peihong Su +14 more
wiley +1 more source
Supratentorial Dural Venous Channel (SDVC): Imaging Anatomy Evaluated on CT Venography. [PDF]
Mizushima S +5 more
europepmc +1 more source
A Small‐Molecule DEPTAC Rescues Cognitive Deficits by Targeted Dephosphorylation of Pathological Tau
TP2 is a fully synthetic small‐molecule dephosphorylation‐targeting chimera that recruits endogenous PP2A‐Bα to Tau, enabling targeted removal of pathological phosphate modifications. In two tauopathy mouse models, systemic TP2 reduces Tau pathology, preserves neuronal and synaptic integrity, improves neuroimmune homeostasis, and rescues cognition ...
Fei Sun +12 more
wiley +1 more source
Long-term outcome of stenting for the iliac vein stenosis with ipsilateral arterio-venous graft; a case series. [PDF]
Shi Y, Bao X, Fu X, Mi L, Liu S, Wu C.
europepmc +1 more source
Self‑amplifying PCSK9–LOX‑1 feedback axis drives atherosclerotic progression by promoting oxLDL generation and endothelial uptake. A dual‑targeting nanoplatform (siPCSK9@PEAL NPs‑aL) is constructed to simultaneously silence hepatic PCSK9 for lipid lowering and block plaque LOX‑1 for anti‑inflammation.
Yi Duan +7 more
wiley +1 more source

